What actually drives the decision
Patients often arrive with an angiogram report showing a percentage and expect a straight answer: bypass or stent. In practice, the percentage is one input among several. The coronary anatomy matters more than a single number: which vessels are involved, whether the narrowing sits at a branch point or in the left main stem, how long the diseased segment is, and whether the plaque is calcified. Diffuse disease that runs along a long stretch of artery behaves differently from a short, discrete narrowing.
The second input is the heart muscle itself. The team looks at how well the left ventricle pumps and whether areas of muscle are starved of blood but still viable. A weak pump or evidence of impaired function changes the balance of risk. The third input is the patient: age, diabetes, kidney function, lung disease, previous bypass or stents, bleeding risk and frailty all affect which procedure is safer for that individual.
Guidance from major cardiac societies frames this as a heart-team decision rather than a single specialist's preference. The 2018 European Society of Cardiology and European Association for Cardio-Thoracic Surgery guidelines on myocardial revascularisation recommend that patients with complex coronary disease be discussed by a team including interventional cardiology and cardiac surgery. That is the model to ask about when you seek care in China.
One practical consequence: a report that gives a percentage narrowing does not by itself establish that you need either procedure. Ask whether the narrowing is functionally significant, whether the anatomy is suitable for a stent, and whether the team has considered both options. Those are clinical questions for the treating clinicians, not something an article or a coordinator can settle.
Where stenting tends to fit, and where it does not
Percutaneous coronary intervention, usually with a drug-eluting stent, opens a narrowed artery from inside using a catheter threaded through the wrist or groin. It avoids a chest incision and generally involves a shorter hospital stay than surgery. For suitable anatomy, particularly disease limited to one or two vessels with discrete lesions, it can be an effective way to restore blood flow.
Stenting becomes more complicated when disease is widespread, when the left main coronary artery is involved, when there are multiple long blockages, or when the patient has diabetes with multivessel disease. In these situations, trials and guidelines have generally found bypass surgery offers more durable results, though the trade-off is a bigger operation and longer recovery. The decision is not that stenting is 'worse' in general; it is that the anatomy and the patient's overall risk profile point one way or the other.
Stent technology and technique continue to evolve, and the evidence base is not frozen. A heart team assessing you today should be able to explain why a particular option fits your anatomy, what the alternatives are, and what the short- and long-term trade-offs look like. Ask them directly what would make them change their recommendation.
Where bypass surgery tends to fit
Coronary artery bypass grafting uses a blood vessel taken from the chest wall, arm or leg to route blood around a blocked coronary artery. It requires general anaesthesia, opening the chest and a period on a heart-lung machine or, in some cases, an off-pump technique. Recovery is longer than after stenting, and the operation carries its own risks, including bleeding, infection, stroke and cognitive changes.
Bypass is often favoured for left main disease, three-vessel disease, and multivessel disease in people with diabetes, based on randomised trials and guideline recommendations. It can also be the better route when stents are unlikely to work well because of calcification or the length of the diseased segment. The internal mammary artery, when used to bypass the left anterior descending artery, has shown particularly durable results in long-term studies.
The trade-off is real: a larger operation with a longer initial recovery, in exchange for potentially fewer repeat procedures over the years. That balance is exactly what the heart team should discuss with you, using your own anatomy and health status rather than general statistics alone.
Records that help a team assess you properly
If you are considering care in China, the quality of the initial assessment depends heavily on what records you can provide. A useful set usually includes the coronary angiogram images themselves, not just the written report, because the team needs to see the anatomy. Also helpful: a recent echocardiogram with ejection fraction, blood tests including kidney function and blood counts, a list of current medicines with doses, and any previous stent or bypass records.
You do not need to send a complete archive at first contact. A short summary of the diagnosis, the main question and the key reports is enough to start. The receiving hospital will tell you what else it needs. Ask specifically whether they want the angiogram on disc or via a secure transfer, and whether they need recent blood tests before an appointment.
Be cautious about assuming that one set of records settles the decision. A records-based review can clarify the anatomy and the options, but the final recommendation usually depends on an in-person assessment, and sometimes on further imaging or a functional test that the treating team orders. The hospital, not the coordinator, decides whether a procedure is suitable.
Questions worth asking the heart team
A useful consultation is one where you leave understanding why one option was recommended over the other. Ask which coronary arteries are affected and whether the left main artery is involved. Ask how many vessels have significant disease and whether the narrowing is functionally significant. Ask what your ejection fraction is and whether any heart muscle is permanently damaged.
Ask whether both bypass and stenting are technically possible for your anatomy, and if not, why. Ask what the team expects in terms of repeat procedures, and what the main risks are for you specifically, given your age, diabetes, kidney function and other conditions. Ask who will make the final decision and whether a heart-team discussion is part of the process.
It is reasonable to ask about the experience of the centre with your type of case, but be wary of anyone who promises a specific outcome or a named surgeon without confirmation. Clinical judgement belongs to the treating team, and a second opinion is a legitimate way to test a recommendation, not a sign of distrust.
Practical next steps for care in China
If you are exploring treatment in China, the first step is a short enquiry describing your diagnosis and main question, with the key reports attached or offered. ChinaSpecialistCare's team can check what information is available, identify what is missing and suggest a relevant next step; this initial review is free and is not a diagnosis or a promise of acceptance. A proxy consultation, where a doctor takes your records to a hospital specialist while you remain at home, is optional and not a prerequisite for every appointment.
For confirmed services, hospital and treatment coordination can support admission preparation and arrangements after hospital acceptance, but the hospital decides suitability and the clinical plan. Hospital fees, our coordination fees and travel costs are separate, and you should ask for a written quote that sets out what each covers. For context on the two procedures, see the ChinaSpecialistCare references on coronary bypass surgery and coronary angiography and PCI, and the cardiac surgery specialty page.
Urgent symptoms such as chest pain at rest, worsening breathlessness or fainting need local emergency assessment, not an overseas planning enquiry. For non-urgent decisions, gather your angiogram images, recent echocardiogram and medicine list, then ask the heart team the questions above before committing to travel.
Sources & scope of this guide
References and official service information relevant to this guide.
- Thoracic Surgery
- Related treatment reference
- Coronary Artery Disease | CAD | MedlinePlus
- Coronary artery bypass graft - NHS
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
